1.25
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TLRY?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.9505
Offen:
$0.961
24-Stunden-Volumen:
187.84M
Relative Volume:
4.56
Marktkapitalisierung:
$1.38B
Einnahmen:
$829.22M
Nettoeinkommen (Verlust:
$-248.96M
KGV:
-4.1667
EPS:
-0.3
Netto-Cashflow:
$-92.10M
1W Leistung:
+102.53%
1M Leistung:
+115.33%
6M Leistung:
+32.51%
1J Leistung:
-32.98%
Tilray Brands Inc Stock (TLRY) Company Profile
Firmenname
Tilray Brands Inc
Sektor
Telefon
519.322.8800
Adresse
655 MADISON AVENUE, NEW YORK
Vergleichen Sie TLRY mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TLRY
Tilray Brands Inc
|
1.25 | 1.04B | 829.22M | -248.96M | -92.10M | -0.30 |
![]()
ZTS
Zoetis Inc
|
152.44 | 66.38B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.20B | 29.96B | 957.25M | 5.31B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.69 | 42.99B | 14.26B | 1.98B | 0 | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 19.04B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
309.72 | 13.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-04-05 | Bestätigt | Alliance Global Partners | Neutral |
2022-11-02 | Eingeleitet | Bernstein | Mkt Perform |
2022-07-29 | Herabstufung | The Benchmark Company | Hold → Sell |
2022-03-04 | Hochstufung | Canaccord Genuity | Hold → Buy |
2021-11-18 | Eingeleitet | Barclays | Underweight |
2021-11-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2021-06-11 | Herabstufung | CIBC | Sector Outperform → Neutral |
2021-06-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2021-05-11 | Fortgesetzt | Cowen | Outperform |
2021-05-07 | Fortgesetzt | Jefferies | Buy |
2021-05-06 | Eingeleitet | Canaccord Genuity | Buy |
2021-04-28 | Fortgesetzt | BofA Securities | Buy |
2021-02-18 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-02-18 | Herabstufung | The Benchmark Company | Buy → Hold |
2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
2020-11-11 | Herabstufung | Stifel | Hold → Sell |
2020-10-01 | Bestätigt | MKM Partners | Neutral |
2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
2020-05-12 | Bestätigt | The Benchmark Company | Buy |
2020-04-16 | Herabstufung | Jefferies | Hold → Underperform |
2020-04-09 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
2020-01-13 | Eingeleitet | BofA/Merrill | Neutral |
2019-11-13 | Bestätigt | The Benchmark Company | Buy |
2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
2019-10-22 | Bestätigt | Piper Jaffray | Overweight |
2019-09-20 | Eingeleitet | MKM Partners | Neutral |
2019-08-14 | Bestätigt | The Benchmark Company | Buy |
2019-07-17 | Eingeleitet | Ladenburg Thalmann | Neutral |
2019-06-28 | Eingeleitet | Consumer Edge Research | Overweight |
2019-06-06 | Eingeleitet | Stifel | Hold |
2019-06-05 | Eingeleitet | Oppenheimer | Perform |
2019-05-15 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
2019-05-13 | Eingeleitet | Alliance Global Partners | Neutral |
Alle ansehen
Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten
Earnings live: CoreWeave stock tumbles 20%, Cava falls, Cisco posts slight beat on AI demand - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Trading 14.4% HigherWhat's Next? - MarketBeat
Tilray Brands (NASDAQ:TLRY) Shares Up 17.3%Here's Why - MarketBeat
Traders Purchase Large Volume of Tilray Brands Call Options (NASDAQ:TLRY) - MarketBeat
Breakout Traders Target Tilray Brands Inc. on Recovery SetupJuly 2025 Volume & High Return Trade Guides - beatles.ru
Promising Cannabis Stocks To Add to Your WatchlistAugust 13th - MarketBeat
This Cannabis Stock Popped 26% Today After Announcing Partnership With An Italian Company – Do You Own It? - Stocktwits
Tilray Brands (NASDAQ:TLRY) Shares Gap UpHere's What Happened - MarketBeat
What's Going On With Tilray Brands Stock Today? - Benzinga
Tilray (TLRY) Stock Trades Up, Here Is Why - TradingView
Tilray Brands to continue Italian expansion with new partnership - MMJDaily
2 Stocks Down More Than 90% That Still Aren't Worth Buying - Mitrade
Tilray’s Meteoric Rise: Analyzing the Surge - StocksToTrade
Why Tilray Should Be Reduced: Assessing the Long-Term Viability and Risk-Reward Profile - AInvest
Tilray expands access to medical cannabis extracts in Italy | 2025-08-13 | Investing News - Stockhouse
Why This Cannabis Penny Stock Could Be Wall Street’s Next Meme Trade Breakout - Yahoo Finance
Why Tilray Should Be Reduced (NASDAQ:TLRY) - Seeking Alpha
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Cannabis Extracts - Cannabis Business Times
Tilray Brands Unit Forms Partnership to Increase Access to Medical Cannabis Extracts in Italy - MarketScreener
Strategic Alliances and Market Maturity: Tilray Medical's European Expansion as a Catalyst for Medical Cannabis Adoption - AInvest
Tilray Medical Forms Partnership in Italy to Broaden Access to Medical Cannabis Extracts - MarketScreener
Tilray Medical Forms Strategic Partnership in Italy to Broaden A - GuruFocus
Tilray Brief: Tilray's FL Group Teams Up with Molteni, a Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies - MarketScreener
Tilray Brief: Tilray Medical Forming Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts - MarketScreener
Tilray's Strategic Expansion in Italy: A Catalyst for Growth in the European Medical Cannabis Market - AInvest
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts - GlobeNewswire
TLRY Q2 Deep Dive: Regulatory Delays, Margin Focus, and International Momentum Shape Results - Yahoo Finance
Can Tilray (TLRY) Broaden Its US Reach Through New Cannabis Beverage Offerings and Evolving Regulation? - simplywall.st
Tilray Brands, Inc. shares fall 1.68% after-hours following the expansion of its hemp-derived Delta-9 THC beverage portfolio. - AInvest
Tilray's 3.32% Rally and 31.36% Volume Spike to 350th as U.S. Cannabis Reclassification Hopes Build - AInvest
Earnings live: CoreWeave, Circle slide as investors scrutinize post-IPO results, Cava stock plunges - Yahoo Finance
Tilray Expands Hemp-Derived THC Beverage Offerings - Bottle Raiders
Cannabis ETFs Light Up As Trump Eyes Marijuana Reclassification - Benzinga
Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg - The National Law Review
Tilray Brands (NASDAQ:TLRY) Stock Price Up 9.2%Here's What Happened - MarketBeat
Promising Cannabis Stocks To Keep An Eye OnAugust 12th - MarketBeat
Tilray Brands (NASDAQ:TLRY) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Tilray Revamps US THC Drinks with Higher Dosage Options - Brewbound
What's Going On With Tilray Stock Today? - Benzinga
Tilray, B&G Foods, SunOpta, Hain Celestial, and TreeHouse Foods Stocks Trade Up, What You Need To Know - TradingView
Trump Contemplates Cannabis Reclassification, Sparking Marijuana Stock Surge - StocksToTrade
Tilray extends gains on Trump comment about cutting pot's classification to a less-dangerous rank - MarketWatch
Tilray’s Buzzing Higher: New THC Beverages and Political Winds Spark a Stock Surge! - RagingBull
Explainer: How US marijuana reclassification could help cannabis companies - Reuters
Is Tilray stock price rally a trap? history suggests selling - Invezz
Trump Mulls Marijuana Reform Boosting Cannabis Market - timothysykes.com
Stock Movers: Tilray Brands, Gildan Activewear, Intel - Bloomberg.com
Stock Movers: Circle, Tilray Brands, Venture Global - Bloomberg.com
Tilray Stocks Surge: What’s Behind the Rise? - StocksToTrade
Tilray Surge: What Does It Mean? - timothysykes.com
Tilray Revamps U.S. THC Drinks With Higher Dosage Options - BevNET.com
Finanzdaten der Tilray Brands Inc-Aktie (TLRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):